Know Labs announces KnowU wearable non-invasive CGM with FDA-submission sensor

USBC, Inc.

KnowU integrates proprietary RF sensor intended for FDA clearance, tested stable and accurate in lab.
Device is smaller and lighter than June 2023 prototype, with on-board computing and machine learning.
Wearable via adhesive or strap; features rechargeable battery and companion mobile app.
Company plans to deploy KnowU in large-scale clinical trials in 2024 while refining algorithms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.